Med Spas Now Prescribe GLP-1s And Hormones. Most Lack The Infrastructure. Compliance Is Not A Marketing Line.
Med spas have expanded well beyond Botox, filler, microneedling, lasers, chemical peels, and skin treatments into GLP-1s, hormones, peptides, and broader wellness services. The traditional aesthetics business is becoming a hybrid between a wellness clinic and a medical practice, yet many operators treat prescription-based wellness as simply another menu item with a price tag and a marketing plan. Apex Aesthetic Consulting flags the gap: these services require actual medical-practice infrastructure to support patient care and regulatory compliance.
The underlying principle here is scope drift, the gradual expansion of services beyond a business's operational and regulatory competence. When an aesthetics clinic adds prescription-based treatments without upgrading its compliance infrastructure, it is not innovating. It is accumulating liability. The lesson for any reader is simple: adding a capability is not the same as being qualified to deliver it.
Apex Aesthetic Consulting published the analysis on med spa compliance gaps. They identify the core problem as infrastructure failing to keep pace with service expansion.
- Pick any AI assistant and ask it to list the regulatory requirements for prescribing GLP-1 medications in your state. You will get a baseline overview of what compliance actually entails.
- Ask the AI to compare those requirements against what a typical med spa currently has in place, such as physician oversight, patient intake protocols, and follow-up procedures. The output will reveal the gap.
- Request a checklist of infrastructure elements a med spa needs before offering prescription wellness services. Save the list. This is your due diligence framework, not legal advice, but a starting point for understanding scope.